Related Experiment Video
Updated: Aug 1, 2026
08:48
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
3.0K
2-deoxy-D-glucose as India's Response to COVID-19: A Commitment or Conceit?
Ritwik Ghosh1, Dipayan Roy2, Subhankar Chatterjee3
1Department of General Medicine, Burdwan Medical College & Hospital, Burdwan, West Bengal, India.
Summary
The anticancer drug 2-deoxy-d-glucose (2-DG) shows promise for treating COVID-19 by inhibiting viral replication. However, its recent approval in India is premature due to limited peer-reviewed clinical data and unaddressed safety concerns.
Area of Science:
- Pharmacology
- Virology
- Immunology
Background:
- 2-deoxy-d-glucose (2-DG) is an anticancer drug with demonstrated immunomodulatory functions.
- Preclinical studies suggest 2-DG can inhibit viral replication and mitigate cytokine storms associated with COVID-19.
Purpose of the Study:
- To critically evaluate the recent approval of 2-deoxy-d-glucose (2-DG) for moderate to severe COVID-19 in India.
- To assess whether the approval was a well-considered strategy for long-term COVID-19 management or an impulsive decision.
Main Methods:
- Review of existing scientific literature on 2-DG's antiviral and immunomodulatory effects.
- Analysis of the clinical trial data underpinning the drug's approval in India.
- Assessment of statistical rigor, safety profile, and peer-review status of supporting studies.
Main Results:
- While 2-DG exhibits potential in preclinical models, clinical trial data supporting its efficacy and safety in COVID-19 patients is limited and not yet peer-reviewed.
- Concerns regarding statistical validity and safety profile remain unaddressed.
- The drug's immunomodulatory and antiviral mechanisms require further robust clinical validation.
Conclusions:
- The approval of 2-DG for COVID-19 treatment in India appears premature.
- Further rigorous, peer-reviewed clinical trials are necessary to establish the drug's efficacy and safety profile.
- The long-term benefits and risks of 2-DG in COVID-19 management require comprehensive investigation before widespread adoption.
Related Concept Videos
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:23Stringent Response in E. coli
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:29Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...